Has Genomics Failed to Deliver?

Table of Contents

The Early Promise of Genomics

Genomics Pales Compared with Biotech

Can Genomics Jumpstart a Broad Portfolio?

Genomics-Derived Clinical Pipelines

• Celera Genomics
• CuraGen
• deCode Genetics
• Exelixis
• ExonHit
• Human Genome Sciences and GlaxoSmithKline
• Rigel
• ZymoGenetics

SWOT Analysis

• Strengths
• Weaknesses
• Opportunities
• Threats

Evolving Business Strategies

• Celera Genomics
• Millennium Pharmaceuticals
• HGS-CoGenesys
• Nuvelo
• Incyte Pharmaceuticals

Outlook

• Personalized Medicine
• Genomics-Derived Therapeutics
• Genomics-Derived Diagnostics